RNVA Rennova Health

RENNOVA HEALTH GIVES UPDATE ON SECOND QUARTER

RENNOVA HEALTH GIVES UPDATE ON SECOND QUARTER

WEST PALM BEACH, Fla, July 12, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its second rural hospital in Tennessee on June 1, 2018, announces that its second quarter revenue has shown significant growth.

Rennova is pleased to announce preliminary second quarter net revenues of approximately $3.42 million. This number remains subject to final review and potential adjustment. This represents an increase of approximately $1.82 million from the reported net revenues from the first quarter and includes the first month from Rennova’s second hospital which it acquired on June 1, 2018. The Company continues to take a conservative position on revenue recognition in hospital operations and will maintain this position until we have adequate historical months to evidence total collection rates.

The acquired hospital, Jamestown TN Medical Center, received confirmation from the Centers for Medicare and Medicaid Services on June 29, that they had processed and approved the Change of Ownership and Provider Tie-in process. Billing has now started and the Company believes it will receive its first collections in a matter of weeks.

“We are pleased to have our second hospital starting to add to revenues and look forward to receipt of our first payments for services provided,” said Seamus Lagan, CEO of Rennova. “We remain confident that our two hospitals will be profitable and contribute in excess of $2 million a month to sales revenue in full operation and we look forward to exploring other opportunities for expansion of revenues or acquisition in the same geographic location.”

Rennova is also pleased to announce that it has ordered a new 64 slice CT scanner for its Oneida based hospital. The new state of the art, high resolution machine should be installed and in operation before the end of July. This addition will replace the existing aged machine and increase the services that can be offered to the communities served and to local physicians that currently send patients to other hospitals for high resolution scans. The Company expects this investment to immediately create increased revenues.

“We look forward to a significant improvement in the revenues and performance in Rennova in the coming quarters,” said Marlene McLennan, the recently appointed CFO of Rennova. “We expect to file our second quarter financial report to June 30 on time by August 14 and are making every effort to have it completed and filed earlier if possible”.

About Rennova Health, Inc.

Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit .

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission.  The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

# # #

Contacts: 
Rennova Health, Inc.
Sebastien Sainsbury, 561-666-9818
 
EN
12/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Rennova Health

 PRESS RELEASE

RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TEC...

RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES WEST PALM BEACH, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce that it has entered into two stock exchange agreements with FOXO Technologies, Inc., an NYSE American-listed company (“FOXO”)(NYSE American: FOXO). In the first agreement, Rennova’s equity in Myrtle Recovery Centers, Inc., the Company’s behavioral health services subsidiary, was exchanged for $500,000 of common stock (which will be issued by FOXO on approval by t...

 PRESS RELEASE

RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE...

RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institutional warrant holders agreed that, with regard to Series B Warrants to acquire 101,350,000,000 shares of common stock, subject to certain terms, the termination date of such Warrants would be...

 PRESS RELEASE

RENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERS

RENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERS WEST PALM BEACH, Fla., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer, Seamus Lagan provides the following message to shareholders. Dear Fellow Shareholders, As we begin 2024, I want to provide an update on some of our recent accomplishments and outline our plans for the future. Our efforts in recent years to build and sustain a viable business model for our healthcare services operations have gained momentum. 2023 was a significant year for the Company both operationally ...

 PRESS RELEASE

RENNOVA HEALTH, INC. ANNOUNCES THE OPENING OF ITS NONRESIDENTIAL OFFIC...

RENNOVA HEALTH, INC. ANNOUNCES THE OPENING OF ITS NONRESIDENTIAL OFFICE-BASED OPIATE TREATMENT FACILITY WEST PALM BEACH, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce that its behavioral health services subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”), has opened a Nonresidential Office-Based Opiate Treatment Facility (“OBOT”). The facility began accepting patients on November 1, 2023 and is located adjacent to Myrtle’s alcohol and drug treatment facility in Oneida, Tennessee. “We are delighted to further develop our Myrtle strategy,”...

 PRESS RELEASE

RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING

RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING WEST PALM BEACH, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce a significant debt restructuring with its primary institutional investors. The restructuring extends the maturity date of approximately $8.2 million of secured debt to December 31, 2025, waives historical events of default and removes and/or modifies certain events of default and definitions. In addition, the Company does not expect to recognize default interest in future periods subject to remaining in compliance wi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch